Skip to main content
Premium Trial:

Request an Annual Quote

Japanese Companies Invest $11M in SomaLogic for Asian Office, Array Collaboration

NEW YORK, Dec. 17 (GenomeWeb News) - Two Japanese companies have invested $11 million in SomaLogic, the company said today.


Mitsui & Co, an earlier investor in SomaLogic, has invested $10 million in the company, which will support the opening of a joint division of the companies in Asia, while plastics manufacturer Sumitomo Bakelite has invested $1 million, and will collaborate with SomaLogic to develop surfaces for the company's aptamer microarrays, SomaLogic said.


"The combined investments from Mitsui and Sumitomo Bakelite greatly advance our shared goal of commercializing SomaLogic's technology and establishing a presence in Asia," stated Dr. Larry Gold, SomaLogic's Chairman of the Board, Chief Scientific Officer and the inventor of aptamers. "As strong regional partners they will help us build the relationships critical to success in this region."


SomaLogic, of Boulder, Colorado, is developing protein microarrays using aptamers, single-stranded DNA and RNA molecules that specifically bind to target molecules with high affinity.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.